Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 241 Less Arrow 26 More Arrow 56
Earnings before taxes -24,046 More Arrow -23,199 More Arrow -11,790
EBITDA -24,266 More Arrow -23,455 More Arrow -11,831
Total assets 21,986 Less Arrow 18,112 More Arrow 42,558
Current assets 16,262 Less Arrow 12,768 More Arrow 37,048
Current liabilities 4,402 Less Arrow 2,853 More Arrow 2,907
Equity capital 16,723 Less Arrow 14,455 More Arrow 38,822
- share capital 4,178 Less Arrow 1,703 More Arrow 1,755
Employees (average) 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 76.1% More Arrow 79.8% More Arrow 91.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -108.3% Less Arrow -127.9% More Arrow -27.6%
Current ratio 369.4% More Arrow 447.5% More Arrow 1274.4%
Return on equity (ROE) -143.8% Less Arrow -160.5% More Arrow -30.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 50%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.